Thermo Fisher Scientific INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Capital Management has reported beneficial ownership of 28,008,822 shares, representing 7.53% of Thermo Fisher Scientific's common stock as of March 31, 2026.
NYSE
The Vanguard Group has reported a 0% beneficial ownership in Thermo Fisher Scientific Inc. following an internal realignment and disaggregated reporting.